Диссертация (1141192), страница 16
Текст из файла (страница 16)
Jensen, J. Viby-Mogensen // Acta Anaesthesiol.Scand. – 1995. – Vol. 39. – P.150-156.124. Joshi, G. Procedure-specific pain management: the road to improve postsurgical pain management? [Теxt] / G. Joshi, H. Kehlet // Anesthesiology. – 2013. – Vol. 118, № 4. – P. 780-782.125. Kalow, W.
The relation between dose of succinylcholine and duration of apnea in man [Теxt] / W. Kalow, D.R. Gunn // J Pharmacol Ехр Ther.– 1957. – Vol. 120. – P. 203-214.126. Kehlet, H. Multimodal approach to control postoperative pathophysiology and rehabilitation [Теxt] / H. Kehlet // Br. J. Anaesth. – 1997. –Vol. 78, № 5. – P.606–617.127. Kehlet, H. Persistent postsurgical pain: Risk factors and prevention [Теxt] / H.
Kehlet, T. Jensen, C. Woolf // Lancet. – 2006. – Vol. 367. –P. 1618–1625.128. Kopf, A. Guide to pain management in low-resource settings[Теxt] / A. Kopf, N.B. Patel. – IASP Press, 2010. – 371p.129.Lassen, D. The pharmacogenetics of tramadol [Теxt] / D. Las-sen, P. Damkier, K. Brosen // Clin Pharmacokinet. – 2015. – Vol. 54, № 8. –P. 825-836.130. Lawler, P.G. An assessment of the consistency of ASA physicalstatus classification allocation [Теxt] / P.G. Lawler // Anaesthesia.
– 1995. –Vol.50, №3. – P.195–199.99131. Leppert, W. CYP2D6 in the metabolism of opioids for mild tomoderate pain [Теxt] / W. Leppert // Pharmacology. – 2011. – Vol. 87. – P.274–285.132. Local analgesic effect of tramadol is mediated by opioid receptorsin late postoperative pain after plantar incision in rats [Теxt] / de Oliveira Junior JO // J Pain Res. – 2016. – Vol.
17, № 9. – P. 797-802.133. Loss-of-function polymorphisms in the organic cation transporterOCT1 are associated with reduced postoperative tramadol consumption [Теxt]/ U.M. Stamer [еt al.] // Pain. – 2016. – Vol. 157, № 11. – P. 2467-2475.134. McGraw, J. Cytochrome P450 variations in different ethnic populations [Теxt] / J.
McGraw, D. Waller // Expert Opin Drug Metab Toxicol. –2012. – Vol. 8, № 3. – P. 371–382.135. McNicol, E.D. Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain [Теxt] /E.D.McNicol, M.C. Ferguson, J. Hudcova // Cochrane Database Syst Rev. – 2015.– Vol.
6. – P. CD003348. doi: 10.1002/14651858.CD003348.pub3.136.Minami, K. What is the main mechanism of tramadol? [Теxt] / K.Minami, J. Ogata, Y. Uezono // Naunyn Schmiedebergs Arch Pharmacol.– 2015. – Vol. 388, № 10. – P.999-1007.137. Monitoring sedation status over time in ICU patients: reliabilityand validity of the Richmond Agitation-Sedation Scale (RASS) [Теxt] / E.W.Ely [еt al.] // JAMA.
2003. – Vol. 11, №289 (22). – P. 2983-2991.138.Moraes, F. A decade of human genome project conclusion: Sci-entific diffusion about our genome knowledge [Теxt] / F. Moraes, A. Góes //Biochem Mol Biol Educ. – 2016. – Vol. 44, № 3. – P. 215-223.139. Nishiyama, M. Personalized medicine and molecular targets ofdrugs [Теxt] / M. Nishiyama // Nihon Rinsho. – 2010. – Vol. 68, № 10. –P.1917-1922.100140. Nolli, M. Postoperative analgesia in Italy [Теxt] / M.
Nolli, G.Apolone, F. Nicosia // Acta Anaesthesiol Scand. – 1997. – Vol. 41. – P. 573580.141.Open versus laparoscopic surgery: does the surgical technique in-fluence pain outcome? Results from an international registry [Теxt] / R. Allvin[еt al.] // Pain Res Treat. – 2016. – Vol. 2016. doi: 10.1155/2016/4087325142. Pain intensity and pain relief after surgery [Теxt] / C.E.
Klopfenstein [еt al.] // Acta Anaesthesiol Scand. – 2000. – Vol. 44, № 1. – P. 58–62.143. Pain intensity on the first day after surgery [Теxt] / H. Gerbeshagen [еt al.] // Anesthesiology. – 2013. – Vol.118. – P. 934–944.144. Personalized medicine in the age of pharmacoproteomics: a closeup on India and need for social science engagement for responsible innovationin post-proteomic biology [Теxt] / P.J. Reddy [еt al.] // Curr PharmacogenomicsPerson Med. – 2011.
– Vol. 9, № 1. – P.67–75.145. Personalized vascular medicine: individualizing drug therapy[Теxt] / E.M. De Goma [еt al.] // Vascular Med. – 2011. – Vol.16, № 5. – P.391-404.146. Pharmacoenvironmentology – a component of pharmacovigilance[Теxt] / S.Z. Rahman [еt al.] // Environmental Health. – 2007. – Vol.6, №1. –P.20.147. Polomano, R. Perspective on pain management in the 21st century[Теxt] / R. Polomano, C. Dunwoody, D.
Krenzischer // Pain Management Nurs.– 2008. – Vol. 9. – P. 3–10.148. Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114Lactive site mutation of CYP2C9: effect on atypical kinetic metabolism profiles[Теxt] / T.S. Tracy [еt al.] // Drug Metab Dispos. – 2002. – Vol. 30, №4. –P.385–390.149. Polymorphism of µ-opioid receptor gene (OPRM1:c.118A→G)does not protect against opioid-induced resiratory depression despite reduced101analgesic response [Теxt] / R.R. Romberg [еt al.] // Anesthesiology. – 2005. –Vol. 102.
– P.522-530.150. Polymorphismsofdrug-metabolizingenzymesCYP2C9,CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population [Теxt] / E.A. Gaikovitch [еt al.] // Eur J Clin Pharmacol. – 2003. – Vol.59, № 4. – P.303-312.151. Postoperative pain experience: Results from a national survey suggest postoperative pain continues to be undermanaged [Теxt] / J.L. Apfelbaum[еt al.] // Anesth Analg. – 2003. – Vol. 97. – P.534–540.152.
Postoperative pain management – good clinical practice [Теxt] /J.D. Andrés [еt al.]; European society of Regional Anaesthesia and Pain Therapy. – 2005. – 57 p.153. Postoperative pain surveys in Italy from 2006 and 2012: (POPSIand POPSI-2) [Теxt] / F.
Coluzzi [еt al.] // Eur Rev Med Pharmacol Sci. – 2015.– Vol. 19, № 22. – P.4261-4269.154. Predictors of post-caesarean section pain and analgesic consumption [Text] / L. Buhaqiar [еt al.] // J Anaesthesiol Clin Pharmacol – 2011. – Vol.27, №2.
– P.185-191.155. Predictors of postoperative pain and analgesic consumption: aqualitative systematic review [Теxt] / H.Y. Ip [еt al.] // Anesthesiology. – 2009.– Vol. 111, № 3. – P.657-677.156. Procedure-specific risk factor analysis for the development of severe postoperative pain [Теxt] / H. Gerbeshagen [еt al.] // Anesthesiology. –2014. – Vol.120. – P. 1237-1245.157. Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection [Теxt] / R. Barlow [еt al.] // Clin. Nutr. – 2011. – Vol.
30, № 5. – P.560–566.102158. Puntillo, K. Stitch, stitch ... creating an effective pain managementprogram for critically ill patients [Теxt] / K. Puntillo // Am J Crit Care. – 1997.– Vol.6, №4. – P.259-260.159. Qualitats management am Beispiel der postoperativen Schmerztherapie [Теxt] / W. Meissner [еt al.] // Anaesthesist. – 2001.
– Bd. 50, № 9. –S. 661-670.160. Reduced postoperative hospitalization after laparoscopic cholecystectomy [Теxt] / P.A. Grace [еt al.] // Br J Surg. – 1991. – Vol.78. – P.160.161. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication [Теxt] / U.M. Stamer [еt al.] // AnesthAnalg. – 2008. – Vol. 107, № 3. – P.
926-929.162. Ross, J.R. Genetic variation and response to morphine in cancerpatients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects [Теxt] / J.R. Ross, J. Riley,A.B. Taegetmeyer // Cancer. – 2008. – Vol.112, №6.
– P.1390-1403.163. Scudellari, M. Genomics contest underscores challenges of personalized medicine [Теxt] / M. Scudellari // Nat Med. – 2012. – Vol. 18, № 3.– P. 326.164. Searle, R. Pharmacogenomic variability and anaesthesia [Теxt] /R. Searle, P.M. Hopkins// Br J Anaesth.
– 2009. – Vol.103, №1. – P.14-25.165. Sequencing CYP2D6 for the detection of poor-metabolizers inpost-mortem blood samples with tramadol [Теxt] / S. Fonseca [еt al.] // Forensic Sci Int. – 2016. – Vol. 265. – P.153-159.166. Sessler, C.N. Evaluating and monitoring analgesia and sedation inthe intensive care unit [Теxt] / C.N. Sessler, M.J. Grap, M.A.E. Ramsay // CritCare. – 2008. – Vol.12. – P.1-13.167. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: A systematic review and meta-analysis[Теxt] / E.D. McNicol [еt al.] // Br J Anaesth. – 2011.
– Vol.106. – P. 764–775.103168. Snell, P. An exploratory study in the UK of the effectiveness ofthree different pain management regimens for post-caesarean section women[Теxt] / P. Snell, C. Hicks // Midwifery. – 2006. – Vol. 22. – P. 249–261.169.Srinivas, N.R. Differential consequences of tramadol in overdos-ing: dilemma of a polymorphic cytochrome P450 2D6-mediated substrate[Теxt] / N.R.
Srinivas // J Pain Palliat Care Pharmacother. – 2015. – Vol. 29,№ 3. – P. 272-275.170. Standardized treatment protocols in acute postoperative pain therapy: analysis of contents of standardized medicinal concepts [Теxt] / J. Erlenwein [еt al.] // Anaesthesist. – 2015. – Vol. 64, № 3. – P. 218-226.171. The 118A→G polymorphism in the human µ-opioid receptor genemay increase morphine requirements in patients with pain caused by malignantdisease [Теxt] / P. Klepstad [еt al.] // Acta Anaesthesiol Scand. – 2004. – Vol.48. – P. 1232-1239.172. The efficacy of the non-opioid analgesics parecoxib, paracetamoland metamizol for postoperative pain relief after lumbar microdiscectomy[Теxt] / O.U.
Grundmann [еt al.] // Anesth Analg. – 2006. – Vol. 103. – P. 217222.173. The impact of CYP2D6 genetic polymorphisms on postoperativemorphine consumption [Теxt] / K.A. Candiotti [еt al.] // Pain Med. – 2009. –Vol. 10, № 5. – P.799-805.174. The impact of early postoperative pain on health-related quality oflife [Теxt] / R.S. Taylor [еt al.] // Pain Pract. – 2013. – Vol.13, №7. – P.515523.175. The Influence of genotype polymorphism on morphine analgesiceffect for postoperative pain in children [Теxt] / M.G. Lee [еt al.] // Korean JPain.
– 2016. – Vol. 29, № 1. – P.34–39.176. The P4 health spectrum - a predictive, preventive, personalizedand participatory continuum for promoting healthspan [Теxt] / M. Sagner [еtal.] // Prog Cardiovasc Dis. – 2016. – Aug 18.104177. The prevalence of postoperative pain in a sample of 1490 surgicalinpatients [Теxt] / M. Sommer [еt al.] // M Eur J Anaesthesiol. – 2008. – Vol.25,№4. – P.267–274.178. The role of CYP2C9 genotype in the metabolism of diclofenac invivo and in vitro [Теxt] / U. Yasar [еt al.] // Eur.
J. Clin. Pharmacol. – 2001. –Vol. 57. – P.729-735.179. Thomson, A. Why do therapeutic drug monitoring [Теxt] / A.Thomson // The Pharm. Journal. – 2004. – Vol. 273. – P.153-155.180. Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans [Теxt] / С.R.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
